We are live on
!
Find out more
NA
Navellier & Associates Portfolio holdings
AUM
$1.26B
1-Year Est. Return
95.39%
This Quarter
Est. Return
+4.8%
1 Year Est. Return
+95.39%
3 Year Est. Return
+360.87%
5 Year Est. Return
+519.82%
10 Year Est. Return
+3,025.56%
AUM
$834M
AUM Growth
+$96.3M
(+13%)
Cap. Flow
+$92.8M
Cap. Flow
% of AUM
11.13%
Top 10 Holdings %
Top 10 Hldgs %
29.49%
Holding
371
New
54
Increased
201
Reduced
42
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$10M |
| 2 |
Sprouts Farmers Market
SFM
|
+$7.67M |
| 3 |
Coca-Cola Consolidated
COKE
|
+$7.48M |
| 4 |
Progressive
PGR
|
+$5.42M |
| 5 |
Skywest
SKYW
|
+$5.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$12.3M |
| 2 |
CrowdStrike
CRWD
|
+$7.57M |
| 3 |
ConocoPhillips
COP
|
+$5.08M |
| 4 |
Microsoft
MSFT
|
+$4.85M |
| 5 |
Insight Enterprises
NSIT
|
+$4.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 23.52% |
| 2 | Technology | 22.73% |
| 3 | Consumer Staples | 10.26% |
| 4 | Consumer Discretionary | 9.15% |
| 5 | Energy | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Safe Bulkers
SB
$788M
| – | – |
-87,119
| Closed | -$451K |
|
352
Star Bulk Carriers
SBLK
$3.17B
| – | – |
-37,658
| Closed | -$892K |
|
353
SFL Corp
SFL
$1.61B
| – | – |
-58,983
| Closed | -$682K |
|
354
Shell
SHEL
$247B
| – | – |
-17,646
| Closed | -$1.16M |
|
355
Scorpio Tankers
STNG
$3.82B
| – | – |
-10,474
| Closed | -$747K |
|
356
Tidewater
TDW
$4.07B
| – | – |
-13,849
| Closed | -$994K |
|
357
Thermo Fisher Scientific
TMO
$213B
| – | – |
-920
| Closed | -$569K |
|
358
Ultrapar
UGP
$6.85B
| – | – |
-132,819
| Closed | -$515K |
|
359
Ultralife
ULBI
$88.6M
| – | – |
-32,345
| Closed | -$292K |
|
360
Vanguard FTSE Europe ETF
VGK
$31.1B
| – | – |
-11,535
| Closed | -$820K |
|
361
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
| – | – |
-5,495
| Closed | -$846K |
|
362
Xylem
XYL
$28.3B
| – | – |
-1,653
| Closed | -$223K |
|
|
USAP
363
DELISTED
Universal Stainless & Alloy
USAP
| – | – |
-25,040
| Closed | -$967K |
|
|
MRO
364
DELISTED
Marathon Oil Corporation
MRO
| – | – |
-8,976
| Closed | -$239K |
|
|
SVA
365
DELISTED
Sinovac Biotech, Ltd
SVA
| $0 | ﹤0.01% |
14,167
| – | – |
|
Similar funds
NCM
TWP
TBC
TC
HP
DAM
PIA
DP
Navellier & Associates's Q4 2024 Portfolio in Review
As of Q4 2024, Navellier & Associates held 371 positions worth $834M, up 13% from $738M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Navellier & Associates deployed $92.8M of net new capital in Q4 2024, opening 54 new positions and adding to 201 existing holdings. Its largest new stake was Trane Technologies: 12,867 shares worth $4.75M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Novo Nordisk, an estimated $12.3M trimmed.
- Navellier & Associates's largest Q4 2024 buy was Trane Technologies: 12,867 shares worth $4.75M.
- Navellier & Associates added most to ExxonMobil in Q4 2024, an estimated $10M increase.
- Navellier & Associates's biggest Q4 2024 reduction was Novo Nordisk, cutting an estimated $12.3M.
- Navellier & Associates fully exited CrowdStrike in Q4 2024, selling an estimated $7.57M.
- Navellier & Associates's ten largest holdings make up 29% of its $834M portfolio in Q4 2024.
- Navellier & Associates opened 54 new positions and closed 42 in Q4 2024.
- Navellier & Associates's portfolio value rose 13% quarter-over-quarter to $834M.
Based on Navellier & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.